main content start
How do you like the content?
Multiple Myeloma 8m 23s

Treatment of High Risk Myeloma Patients

Published 11 Jul 2022
While treating high risk patients it is critical to address complex biology & maximize the response for individual patients by gaining depth of response & maintaining that response for long duration. To ensure good quality of life patients should have good bone and kidney health. Treatment related side effects such as neuropathy need to be managed well. 3 or 4 drug regimens are commonly used in high-risk patients, 4 drug regimens increase the depth of response and induce MRD (Minimal Residual Disease) compared to 3 drug regimens. Intensification of treatment is important for sustaining good response. In high-risk patients who have not achieved MRD negativity or have achieved CR (complete response) transplantation can improve progression free survival.
high risk myeloma

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Perks of registering with us
Access to Online/Offline Events
Personalized Content
Access to all Features
Hi, can I help?
Chat SupportX
Support Team
Hello, how can I help you today?
Please select one of the below options.

Find Information

Unable to Login or Register

Want to share feedback